An update on the first clinical trial evaluating a pluripotent stem cell‑derived neural stem cell therapy for Huntington’s ...

Can AI deliver the productivity gains pharma needs?

The Medicines and Healthcare products Regulatory Agency has authorised Jascayd (nerandomilast) for adults with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis, marking the first new ...

Grünenthal has received Orphan Drug and Rare Pediatric Disease designations from the US Food and Drug Administration for ...

Compass Pathways has announced six‑month results from its second phase 3 trial of COMP360, its synthetic formulation of ...

The UK’s ageing population is reshaping healthcare demand in largely predictable and preventable ways. Nearly one in five ...

Last year I engineered an advanced agentic AI pharma strategy development application. One year later, after many ...

Novartis has secured European Commission approval for Itvisma for the treatment of children aged two years and older, as well ...

Applications have opened for the ninth cohort of KQ Labs, the national accelerator for data‑driven health start‑ups delivered ...

R1 Therapeutics has formed a scientific advisory board comprising seven internationally recognised nephrology experts as the ...

AlzeCure Pharma has signed an out‑licensing and collaboration agreement with Danish biotech QuantumCell ApS, granting global ...

Option offers once‑daily semaglutide tablets for adults living with obesity A first‑of‑its‑kind daily GLP‑1 weight‑loss pill has launched in the UK, expanding treatment options for adults living with ...